XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.23.2

Earnings Per Share ("EPS") | 3 Months Ended
--- | ---
Jul. 29, 2023
Earnings Per Share [Abstract] |
Earnings Per Share ("EPS") | Earnings Per Share ("EPS") In the first quarter of fiscal 2024, we adopted ASU 2020-06. Upon adoption, we prospectively utilized the if-converted method to calculate the dilutive impact of our convertible note issued on May 11, 2023 (the "Convertible Note"). See "Note 7. Financing Agreements" of the Notes to our Condensed Consolidated Financial Statements included in this Form 10-Q for further information on the Convertible Note. Under the if-converted method, the Convertible Note is assumed to be converted into common stock at the beginning of the reporting period, and the resulting shares are included in the denominator of the calculation. In addition, interest charges, net of any income tax effects, are added back to the numerator of the calculation. The following is a reconciliation of the net income (loss) and common share amounts used in the calculation of basic and diluted EPS for the three months ended July 29, 2023 and July 30, 2022:
| Three Months Ended |  |
| July 29, 2023 |  | July 30, 2022 |  |  |  |
Earnings per share - basic |  |  |  |  |  |  |
Net income (loss) | $ | 19,196 |  |  | $ | (5,326) |  |  |  |  |
Weighted average shares outstanding | 45,645 |  |  | 45,097 |  |  |  |  |
Basic earnings (loss) per share | $ | 0.42 |  |  | $ | (0.12) |  |  |  |  |
Earnings per share - diluted |  |  |  |  |  |  |
Net income (loss) | $ | 19,196 |  |  | $ | (5,326) |  |  |  |  |
Diluted net income (loss) | $ | 19,196 |  |  | $ | (5,326) |  |  |  |  |
Weighted average common shares outstanding | 45,645 |  |  | 45,097 |  |  |  |  |
Dilution associated with stock compensation plans | 553 |  |  | — |  |  |  |  |
Weighted average common shares outstanding, assuming dilution | 46,198 |  |  | 45,097 |  |  |  |  |
Diluted earnings (loss) per share | $ | 0.42 |  |  | $ | (0.12) |  |  |  |  |
Options outstanding to purchase 1,326 shares of common stock with a weighted average exercise price of $8.97 for the three months ended July 29, 2023 and 2,102 shares of common stock with a weighted average exercise price of $8.12 for the three months ended July 30, 2022 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration